Hikma Pharmaceuticals Plc

Hikma Pharmaceuticals (HIK)

Company name:Hikma Pharmaceuticals Plc
EPIC:HIKTrading Currency:GBX
Market Sector:FS10ISIN:GB00B0LCW083
Market Segment:SET1Share Type:DE
WWW Address:http://www.hikma.com/Description:ORD SHS 10P
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 1,911.00 images.advfn.com/imagesnew/2/gb/up 2.0 [0.10] 1,910.50 1,912.00 1,910.00 1,918.50 1,892.00 68,164
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 4,623.74 241.95 -0.91 89.01 29.80 21.47 1.56 2,212.00 - 1,491.50

Hikma Pharmaceuticals Key Figures

(at previous day's close)
Market Cap.4,623.74m
Shares In Issue241.95m
Prev. Close1,909.00
PE Ratio21.47 
Dividend Yield1.56%
EPS - basic89.01p
Dividend PS29.80p
Dividend Cover- 
Cash Flow PS139.36p
Return On Equity (ROE)16.74%
Operating Margin14.15%
PEG Factor0.16 
EPS Growth Rate133.30%
Dividends PS Growth Rate11.76%
Net Debt1,195.06m
Gross Gearing51.47%
Quick Assets991.96m
Net Working Capital705.74m
Intangibles / Fixed Assets44.95%
Turnover PS670.88p
Pre-Tax Profit PS94.96p
Retained Profit PS64.17p
Cash PS89.45p
Net Cash PS-199.97p
Net Tangible Asset Value PS *297.84p
Net Asset Value PS549.99p
Spread1.50 (0.08%) 

Hikma Pharmaceuticals Balance Sheet

HIK:Liabilities+EQHIK:Assets

Share Price Performance

Sample Period HighLow
1 week1,925.001,859.50
4 weeks1,970.001,859.00
12 weeks2,212.001,859.00
1 year2,212.001,491.50

Share Price Chart (5 years)

Hikma Pharmaceuticals Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week1,898.0013.000.681,859.500.331,900.34
4 weeks1,859.0052.002.801,859.000.341,903.45
12 weeks1,937.50-26.50-1.371,859.000.572,023.92
26 weeks1,617.00294.0018.181,603.000.611,920.39
1 year1,683.00228.0013.551,491.500.641,804.10
3 years1,728.00183.0010.59814.200.721,569.21
5 years2,014.00-103.00-5.11814.200.651,751.72

Hikma Pharmaceuticals Key Management Ratios

Hikma Pharmaceuticals Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio14.17 
PE Ratio21.47 
Tobin's Q Ratio 1.34 
Tobin's Q Ratio (excl. intangibles)1.73 
Dividend Yield1.56%
Market-to-Book Ratio3.50 
Price-to-Pre-Tax Profit PS20.12 
Price-to-Retained Profit PS29.78 
Price-to-Cash Flow PS13.71 
Price-to-Sales PS2.85 
Price-to-Net Tangible Asset Value PS6.33 
Price-to-Cash PS21.36 
Net Working Capital PS291.69 
Price Pct to Working Capital PS6.55%
Earnings Yield4.66%
Average PE18.74 
Years in average4 
PE to PE average114.58%

Hikma Pharmaceuticals Financial Ratios

(Leverage Ratios)
Debt Ratio34.83%
Debt-to-Equity Ratio0.53 
Debt-to-Equity Ratio (excl. Intgbl)0.97 
Debt-to-Equity Market Value0.15 
Net Gearing43.58%
Net Gearing (excl. Intangibles)55.80%
Gross Gearing51.47%
Gross Gearing (excl. Intangibles)65.91%
Gearing Under 1 Year25.54%
Gearing Under 1 Year (excl. Intgbl)32.70%
Assets/Equity2.06 
Cash/Equity16.26 
(Liquidity Ratios)
Net Working Capital to Total Assets25.74%
Current Ratio2.01 
Quick Ratio (Acid Test)1.42 
Liquidity Ratio0.31 
Cash & Equiv/Current Assets15.39%
(Solvency Ratios)
Enterprise Value5,127.95m
CFO/Sales0.21 
CFO/Attributable Profit1.52 
CFO/Assets0.12 
CFO/Debt0.24 
Total Debt/Equity Market Value0.31 
Total Debt/Sales0.87 
Total Debt/Pre-Tax Profit6.14 
Total Debt1,411.49m
Total Debt/Net Current Assets2.00%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth20.72%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth11.08%
Earn drops > 5% in 10yrs5 
Beta (60-Mnth)Beta (36-Mnth)
-0.9081-0.7792

Hikma Pharmaceuticals Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)11.25%
Return On Assets (ROA)6.42%
Net Profit Margin13.62%
Assets Turnover0.47 
Return On Equity (ROE)16.74%
Return On Investment (ROI)8.51%
Dividend Payout Ratio32.48%
Plowback Ratio67.52%
Growth from Plowback Ratio9.33%
Net Income Of Revenues9.57%
(Asset Utilisation Multiples)
Shareholders Equity Turnover1.01 
Fixed Assets Turnover0.96 
Current Assets Turnover0.93 
Net Working Capital Turnover 
Inventory Turnover3.20 
(Other Operating Ratios)
Total Assets-to-Sales2.12 
Debtors-to-Sales56.22%
Debt Collection Period205.19Days

Hikma Pharmaceuticals Dividends

Announcement DateTypeCurr.Dividend AmountPeriod StartPeriod EndEx DateRecord DatePayment DateTotal Dividend Amount
09 Aug 2019InterimUSX14.0031/12/201831/12/201922/08/201923/08/201923/09/2019-
13 Mar 2019FinalUSX26.0031/12/201731/12/201804/04/201905/04/201922/05/201938.00
15 Aug 2018InterimUSX12.0031/12/201731/12/201823/08/201824/08/201821/09/2018-
14 Mar 2018FinalUSX23.0031/12/201631/12/201705/04/201806/04/201824/05/201834.00
17 Aug 2017InterimUSX11.0031/12/201631/12/201724/08/201725/08/201722/09/2017-
15 Mar 2017FinalUSX22.0031/12/201531/12/201606/04/201707/04/201725/05/201733.00
26 Aug 2016InterimUSX11.0031/12/201531/12/201601/09/201602/09/201630/09/2016-
16 Mar 2016FinalUSX21.0031/12/201431/12/201507/04/201608/04/201619/05/201632.00
19 Aug 2015InterimUSX11.0031/12/201431/12/201527/08/201528/08/201525/09/2015-
11 Mar 2015SpecialUSX4.0031/12/201331/12/201416/04/201517/04/201521/05/2015-
11 Mar 2015FinalUSX9.9031/12/201331/12/201416/04/201517/04/201521/05/201516.90
20 Aug 2014SpecialUSX4.0031/12/201331/12/201427/08/201429/08/201426/10/2014-
20 Aug 2014InterimUSX7.0031/12/201331/12/201427/08/201429/08/201426/10/2014-
12 Mar 2014SpecialUSX2.4031/12/201231/12/201323/04/201425/04/201422/05/2014-
12 Mar 2014FinalUSX7.8031/12/201231/12/201323/04/201425/04/201422/05/201412.30
21 Aug 2013SpecialUSX1.9031/12/201231/12/201304/09/201306/09/201307/10/2013-
21 Aug 2013InterimUSX4.5031/12/201231/12/201304/09/201306/09/201307/10/2013-
13 Mar 2013FinalUSX10.0031/12/201131/12/201217/04/201319/04/201323/05/201316.00
16 Aug 2012InterimUSX6.0031/12/201131/12/201229/08/201231/08/201208/10/2012-
14 Mar 2012FinalUSX7.5031/12/201031/12/201118/04/201220/04/201224/05/201213.00
25 Aug 2011InterimUSX5.5031/12/201031/12/201107/09/201109/09/201113/10/2011-
16 Mar 2011FinalUSX7.5031/12/200931/12/201013/04/201115/04/201126/05/201113.00
26 Aug 2010InterimUSX5.5031/12/200931/12/201008/09/201010/09/201014/10/2010-
17 Mar 2010FinalUSX6.5031/12/200831/12/200914/04/201016/04/201027/05/201011.00
17 Mar 2009FinalUSX4.0031/12/200731/12/200829/04/200901/05/200902/06/20097.50
27 Aug 2009InterimUSX4.5030/12/200730/06/200816/09/200918/09/200916/10/2009-
28 Aug 2008InterimUSX3.5030/12/200730/06/200817/09/200819/09/200817/10/2008-
18 Mar 2008FinalUSX4.0001/07/200731/12/200730/04/200802/05/200802/06/20087.50
05 Sep 2007InterimUSX3.5030/12/200630/06/200726/09/200728/09/200726/10/2007-
20 Mar 2007FinalUSX2.1031/12/200531/12/200616/05/200718/05/200718/06/20073.70
13 Sep 2006InterimUSX1.6030/12/200530/06/200627/09/200629/09/200627/10/2006-
25 May 2006FinalUSX0.4731/12/200431/12/200526/04/200628/04/200630/05/20060.47

Hikma Pharmaceuticals Fundamentals

 31 Dec 2015 (USD)31 Dec 2016 (USD)31 Dec 2017 (USD)31 Dec 2018 (USD)
turnover1,440.00100.00%1,950.00100.00%1,936.00100.00%2,070.00100.00%m
pre tax profit318.0022.08%210.0010.77%-738.00-38.12%293.0014.15%m
attributable profit252.0017.50%155.007.95%-843.00-43.54%282.0013.62%m
retained profit188.0013.06%78.004.00%-922.00-47.62%198.009.57%m
eps - basic126.60 66.50 -351.30 117.00 
eps - diluted125.40 66.20 -349.80 116.50 
dividends per share32.00 33.00 34.00 38.00 

Hikma Pharmaceuticals Balance Sheet

 31 Dec 2015 (USD)31 Dec 2016 (USD)31 Dec 2017 (USD)31 Dec 2018 (USD)
HIK:Liabilities+EQHIK:AssetsHIK:Liabilities+EQHIK:AssetsHIK:Liabilities+EQHIK:AssetsHIK:Liabilities+EQHIK:Assets
 31 Dec 2015 (USD)31 Dec 2016 (USD)31 Dec 2017 (USD)31 Dec 2018 (USD)
ASSETS
fixed assets fixed assets507.0019.52%969.0022.21%828.0024.44%870.0024.88%m
intangibles intangibles607.0023.37%1,719.0039.40%785.0023.17%766.0021.90%m
fixed investments fixed investments53.002.04%55.001.26%66.001.95%68.001.94%m
current assets - other current assets - other25.000.96%66.001.51%95.002.80%59.001.69%m
stocks stocks251.009.66%459.0010.52%488.0014.40%528.0015.10%m
debtors debtors561.0021.60%933.0021.38%895.0026.42%930.0026.59%m
cash & securities cash & securities593.0022.83%162.003.71%231.006.82%276.007.89%m
TOTAL2,597.00100%4,363.00100%3,388.00100%3,497.00100%m
LIABILITIES
creditors - short creditors - short592.0022.80%918.0021.04%797.0023.52%893.0025.54%m
creditors - long creditors - long653.0025.14%1,034.0023.70%1,063.0031.38%907.0025.94%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL1,245.0047.94%1,952.0044.74%1,860.0054.90%1,800.0051.47%m
EQUITY
ord cap, reserves ord cap, reserves1,337.0051.48%2,396.0054.92%1,514.0044.69%1,685.0048.18%m
prefs, minorities prefs, minorities15.000.58%15.000.34%14.000.41%12.000.34%m
TOTAL1,352.0052.06%2,411.0055.26%1,528.0045.10%1,697.0048.53%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Hikma Pharmaceuticals Cash Flow Statement

31 Dec 2015 (USD)31 Dec 2016 (USD)31 Dec 2017 (USD)31 Dec 2018 (USD)
Operating CF366.00293.00443.00430.00m
Pre-Financing CF204.00-402.00292.00334.00m
Retained CF281.00-383.0072.0056.00m

Hikma Pharmaceuticals Brokers

NameActivityTypeMnemonicCode
Deutsche Bank AG London BranchMarket Maker(MME)Broker/DealerDEUTDEUTGB2L
Evolution Securities LimitedMarket Maker(MME)Broker/DealerEVOEVBGGB21MMT
Jefferies International LtdMarket Maker(MME)Broker/DealerJEFFJEFFGB2X
J.P. Morgan Securities LtdMarket Maker(MME)Broker/DealerJPMSJPMSGB2L
Citigrp Global Mkt UK EquitiesMarket Maker(MME)Broker/DealerCITISBUKGB21
Merrill Lynch InternationalMarket Maker(MME)Broker/DealerMLSBSNCSGB2LBIC
UBS AGMarket Maker(MME)Broker/DealerUBS.UBSWGB2LEQU
Winterflood Securities LtdMarket Maker(MME)Broker/DealerWINSWNTSGB2LBIC
Your Recent History
LSE
HIK
Hikma Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20191210 10:55:12